packageImiglucerase

imiglucerase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Imiglucerase is an enzyme replacement medicine used to treat Gaucher's disease, a lipid storage disorder that can affect organs such as the liver and spleen. It is authorised in the European Union and is used mainly in specialist care for this rare condition.

Summary written by glm-5.3-flash from Wikidata Q2620206 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:imiglucerase
ATC codes:A16AB02
DrugBank:DB00053
Wikidata:Q2620206
molar mass:55597.4 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown